Diagnosis and classification of autoimmune pancreatitis

Autoimmunity Reviews

Volumn 13, Issue 4-5, 2014, Pages 451-458

  Okazaki, Kazuichi ^a   Tomiyama, Takashi ^a   Mitsuyama, Toshiyuki ^a   Sumimoto, Kimi ^a   Uchida, Kazushige ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Autoimmune pancreatitis; IgG4; IgG4 related disease; Mikulicz disease; Regulatory T cell (Treg)

Indexed keywords

FLUORODEOXYGLUCOSE; GALLIUM; IMMUNOGLOBULIN G4; MERCAPTOPURINE; MYCOPHENOLIC ACID; PREDNISOLONE;

AUTOIMMUNE PANCREATITIS; CD4+ T LYMPHOCYTE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; HYPOPHYSITIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN G4 RELATED DISEASE; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; LUNG LESION; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS BIOPSY; PLASMA CELL; POSITRON EMISSION TOMOGRAPHY; PROSTATITIS; REVIEW; SALIVARY GLAND BIOPSY; SALIVARY GLAND DISEASE; SCINTIGRAPHY; STEROID THERAPY; THYROIDITIS;

AUTOIMMUNE PANCREATITIS; IGG4; IGG4-RELATED DISEASE; MIKULICZ DISEASE; REGULATORY T CELL (TREG);

AUTOIMMUNE DISEASES; FIBROSIS; HUMANS; IMMUNOGLOBULIN G; PANCREATITIS; PRACTICE GUIDELINES AS TOPIC;

EID: 84896319407     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2014.01.010     Document Type: Review

References (60)

1. Sarles H., Sarles J.C., Muratore R., Guien C. Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease?. Am J Dig Dis 1961, 6:688-698.
2. Yoshida K., Toki F., Takeuchi T., Watanabe S., Shiratori K., Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 1995, 40:1561-1568.
3. Okazaki K., Uchida K., Ikeura T., Takaoka M. Current concept and diagnosis of IgG4-related disease in the hepato-bilio-pancreatic system. J Gastroenterol 2013, 48:303-314.
4. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. New Engl J Med 1995, 344:732-738.
5. Okazaki K., Uchida K., Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001, 36:293-302.
6. Pickartz T., Mayerle J., Lerch M. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007, 4:314-323.
7. Kawaguchi K., Koike M., Tsuruta K., Okamoto A., Tabata I., Fujita N. Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas. Hum Pathol 1991, 22:387-395.
8. Kamisawa T., Funata N., Hayashi Y., Eishi Y., Koike M., Tsuruta K., et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003, 38:982-984.
9. Comings D.E., Skubi K.B., Van Eyes J., Motulsky A.G. Familial multifocal fibrosclerosis. Ann Intern Med 1967, 66:884-892.
10. Chari S.T., Kloeppel G., Zhang L., Notohara K., Lerch M.M., Shimosegawa T. Histopathologic and clinical subtypes of autoimmune pancreatitis: the Honolulu consensus document. Pancreas 2010, 39:549-554.
11. Klöppel G., Detlefsen S., Chari S.T., Longnecker D.S., Zamboni G. Autoimmune pancreatitis: the clinicopathological characteristics of the subtype with granulocytic epithelial lesions. J Gastroenterol 2010, 45:787-793.
12. Mikulicz J. Über eine eigenartige symmetrishe Erkrankung der Tränen und Mundspeicheldrüsen 1892, 610-630. Beitr z Chir Fesrschr f Theodor Billroth, Stuttgart.
13. Kuttner H. Ur̈ ber entzur̈ndiche Tumoren der submaaxillar̈ren Speicheldrur̈se. Beitr Klin Chir 1896, 15:815-834.
14. Kamisawa T., Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006, 41:613-625.
15. Yamamoto M., Takahashi H., Ohara M., Suzuki C., Naishiro Y., Yamamoto H., et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006, 16:335-340.
16. Masaki Y., Dong L., Kurose N., Kitagawa K., Morikawa Y., Yamamoto M., et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis 2009, 68:1310-1315.
17. Umehara H., Okazaki K., Masaki Y., Kawano M., Yamamoto M., Saeki T., et al. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 2012, 22:1-14.
18. Umehara H., Okazaki K., Masaki Y., Kawano M., Yamamoto M., Saeki T., et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012, 22:21-30.
19. Deshpande V., Zen Y., Chan J.K., Yi E.E., Sato Y., Yoshino T., et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012, 25:1181-1192.
20. Stone J.H., Khosroshahi A., Deshpande V., Chan J.K., Heathcote J.G., Aalberse R., et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 2012, 64:3061-3067.
21. Okazaki K., Kawa S., Kamisawa T., Shimosegawa T., Tanaka M., Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society Japanese consensus guidelines for management of autoimmune pancreatitis: I. Concept and diagnosis of autoimmune pancreatitis. J Gastroenterol 2010, 45:249-265.
22. Kawa S., Okazaki K., Kamisawa T., Shimosegawa T., Tanaka M., Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis. J Gastroenterol 2010, 45:355-369.
23. Kamisawa T., Okazaki K., Kawa S., Shimosegawa T., Tanaka M., Research Committee for Intractable Pancreatic Disease and Japan Pancreas Society Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 2010, 45:471-477.
24. Chari S.T., Kloeppel G., Zhang L., Notohara K., Lerch M.M., Shimosegawa T., et al. The Autoimmune Pancreatitis International Cooperative Study Group (APICS). Histopathologic and clinical subtypes of autoimmune pancreatitis: the honolulu consensus document. Pancreas 2010, 39:549-554.
25. Shimosegawa T., Chari S.T., Frulloni L., Kamisawa T., Kawa S., Mino-Kenudson M., et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas 2011, 40:352-358.
26. Kamisawa T., Funata N., Hayashi Y., Tsuruta K., Okamoto A., Amemiya K., et al. Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis. Gut 2003, 52:683-687.
27. Saegusa H., Momose M., Kawa S., Hamano H., Ochi Y., Takayama M., et al. Hilar and pancreaticgallium-67 accumulation is characteristic feature of autoimmunepancreatitis. Pancreas 2003, 27:20-25.
28. Erkelens G.W., Vleggaar F.P., Lesterhuis W., van Buuren H.R., van der Werf S.D. Sclerosing pancreato-cholangitis responsive to steroid therapy. Lancet 1999, 354:43-44.
29. Nakazawa T., Ohara H., Yamada T., et al. Atypical primary sclerosing cholangitis cases associated with unusual pancreatitis. Hepatogastroenterology 2001, 48:625-630.
30. Hamano H., Kawa S., Ochi Y., Unno H., Shiba N., Wajiki M., et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002, 359:1403-1404.
31. Uchiyama-Tanaka Y., Mori Y., Kimura T., Watanabe S., Nozaki Y., Fujita K., et al. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis. Am J Kidney Dis 2004, 43:e18-e25.
32. Takeda S., Haratake J., Kasai T., Takaeda C., Takazakura E. IgG4-associated idiopathic tubulointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant 2004, 19:474-476.
33. Shimatsu A., Oki Y., Fujisawa I., Fujisawa I., Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 2009, 56:1033-1041.
34. Komatsu K., Hamano H., Ochi Y., Takayama M., Muraki T., Yoshizawa K., et al. High prevalence of hypothyroidism in patients with autoimmune pancreatitis. Dig Dis Sci 2005, 50:1052-1057.
35. Yoshimura Y., Takeda S., Ieki Y., Takazakura E., Koizumi H., Takagawa K. IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 2006, 45:897-901.
36. Okazaki K., Uchida K., Matsushita M., Takaoka M. How to diagnose autoimmune pancreatitis by the revised Japanese clinical criteria. J Gastroenterol 2007, 42(Suppl. 18):32-38.
37. Ohara H., Nakazawa T., Sano H., Ando T., Okamoto T., Takada H., et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas 2005, 31:232-237.
38. Hamano H., Arakura N., Muraki T., Ozaki Y., Kiyosawa K., Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006, 41:1197-1205.
39. Masaki Y., Sugai S., Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010, 37:1380-1385.
40. Notohara K., Burgart L.J., Yadav D., Chari S., Smyrk T.C. Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinico-pathologic features of 35 cases. Am J Surg Pathol 2003, 27:1119-1127.
41. Zamboni G., Lüttges J., Capelli P., Frulloni L., Cavallini G., Pederzoli P., et al. Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens. Virchows Arch 2004, 445:552-563.
42. Detlefsen S., Bräsen J.H., Zamboni G., Capelli P., Klöppel G. Deposition of complement C3c, immunoglobulin (Ig)G4 and IgG at the basement membrane of pancreatic ducts and acini in autoimmune pancreatitis. Histopathology 2010, 57:825-835.
43. Members of the Criteria Committee for Autoimmune Pancreatitis of the Japan Pancreas Society Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society (2002). J Jpn Pancreas Soc (Suizou) 2002, 17:585-587.
44. Okazaki K., Kawa S., Kamisawa T., Naruse S., Tanaka S., Nishimori I., et al. Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol 2006, 41:626-631.
45. The Japan Pancreas Society, The Ministry of Health and Welfare Investigation Research Team for Intractable Pancreatic Disease Clinical Diagnostic for Autoimmune Pancreatitis 2011 (Proposal) (in Japanese with English abstract). J Jpn Pancreas (Suizo) 2012, 27:17-25.
46. Shimosegawa T., Working Group Members of the Japan Pancreas Society, Research Committee for Intractable Pancreatic Disease by the Ministry of Labor, Health and Welfare of Japan The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for autoimmune pancreatitis. Pancreas 2012, 41:1341-1342.
47. Chari S.T., Smyrk T.C., Levy M.J., Topazian M.D., Takahashi N., Zhang L., et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006, 4:1010-1016.
48. Chari S.T., Takahashi N., Levy M.J., Smyrk T.C., Clain J.E., Pearson R.K., et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol 2009, 7:1097-1103.
49. Kwon S., Kim M.H., Choi E.K. The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus. Pancreas 2007, 34:279-286.
50. Otsuki M., Chung J.B., Okazaki K., Kim M.H., Kamisawa T., Kawa S., et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis. J Gastroenterol 2008, 43:403-408.
51. Pearson R.K., Longnecker D.S., Chari S.T., et al. Controversies in clinical pancreatology: autoimmune pancreatitis: does it exist?. Pancreas 2003, 27:1-13.
52. Schneider A. Lor̈hr JM. [Autoimmune pancreatitis]. Internist (Berl) 2009, 50:318-330.
53. Kawano M., Saeki T., Nakashima H., Nishi S., Yamaguchi Y., Hisano S., et al. Proposal for diagnostic criteria for IgG4-related kidney disease. Clin Exp Nephrol 2011, 15:615-626.
54. Tomiyama T., Uchida K., Matsushita M., Ikeura T., Fukui T., Takaoka M., et al. Comparison of steroid pulse therapy and conventional oral steroid therapy as initial treatment for autoimmune pancreatitis. J Gastroenterol 2011, 46:696-704.
55. Kamisawa T., Okamoto A., Wakabayashi T., Watanabe H., Sawabu N. Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome. Scand J Gastroenterl 2008, 43:609-613.
56. Hirano K., Tada M., Isayama H., et al. Long-term prognosis of autoimmune pancreatitis with and without corticosteroid treatment. Gut 2007, 56:1719-1724.
57. Hart P.A., Kamisawa T., Brugge W.R., Chung J.B., Culver E.L., Czakó L., et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 2013, 62:1771-1776.
58. Ghazale A., Chari S.T., Zhang L., Smyrk T.C., Takahashi N., Levy M.J., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134:706-715.
59. Hart P.A., Topazian M.D., Witzig T.E., Clain J.E., Gleeson F.C., Klebig R.R., et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 2013, 62:1607-1615.
60. Khosroshahi A., Bloch D.B., Deshpande V., Stone J.H. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum Jun 2010, 62(6):1755-1762.